1,25-Dihydroxyvitamin D3 induces splenocyte apoptosis and enhances BALB/c mice sensitivity to toxoplasmosis. 2005

Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
Institut National de la Santé Et de la Recherche Médicale UMR-S 392, Institut de Parasitologie et de Pathologie Tropicale, Faculté de Médicine, 3 rue de Koeberlé, 67000 Strasbourg, France.

The hormonal form of Vitamin D, 1,25-dihydroxyvitamin D3, is well known for its immunosuppressive, anti-proliferative and pro-apoptotic activities. In the present work, we studied the effect of 1,25-dihydroxyvitamin D3 on Toxoplasma gondii-infected mice. We observed that 1,25-dihydroxyvitamin D3 reduces the survival rate of infected mice by up to 37% at day 10 post-infection compared to untreated infected mice (P < 0.0001). IFN-gamma and IL-12p40 levels were significantly reduced by 1,25-dihydroxyvitamin D3 in infected mice sera indicating an inhibition of Th-1-type cytokines. CD4+ T lymphocyte and splenocyte counts were also reduced following 1,25-dihydroxyvitamin D3 treatment and a marked induction of apoptosis, accompanied with down-regulation of the anti-apoptotic proteins Bcl-2 and Bcl-X(L), was observed. The above results indicate that 1,25-dihydroxyvitamin D3 induces splenocyte apoptosis and enhances host susceptibility to toxoplasmosis.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D014123 Toxoplasmosis The acquired form of infection by Toxoplasma gondii in animals and man. Toxoplasma gondii Infection,Infection, Toxoplasma gondii
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
July 1998, Molecular and cellular endocrinology,
Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
May 1998, Clinical and experimental immunology,
Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
February 2006, The Journal of infectious diseases,
Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
February 1999, Journal of cellular physiology,
Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
February 2018, Hypertension research : official journal of the Japanese Society of Hypertension,
Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
December 1989, Proceedings of the National Academy of Sciences of the United States of America,
Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
November 1992, Diabetes,
Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
January 2011, Journal of radiation research,
Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
June 1984, Lancet (London, England),
Rohan Rajapakse, and Marc Mousli, and Alexander W Pfaff, and Béatrice Uring-Lambert, and Luc Marcellin, and Christian Bronner, and Michaël Jeanblanc, and Odile Villard, and Valérie Letscher-Bru, and Jean-Paul Klein, and Ermanno Candolfi
September 1999, Journal of dairy science,
Copied contents to your clipboard!